In silico study of Sobuzoxane for VEGF-B mediated lymphangiogenesis targeting triple negative breast cancer
, , and
BIO Web Conf., 228 (2026) 02002
Published online: 11 March 2026
DOI: 10.1051/bioconf/202622802002

